Authors
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Take-Home Points for the Treatment of AMD and DMEDavid A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
The subthreshold laser’s role in retinal vascular diseaseCombination therapy benefits from laser in the mix for DME, other conditions
Latest:
Laser therapy may offer fast-acting option for CSR resolutionPatients tolerate therapy well; high safety profile allows re-treatment as necessary
Latest:
Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + LombBausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
Latest:
Comparing suitable naïve versus pre-treated DME patientsJavier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Latest:
DR/DME: Ongoing Clinical Trials and New Diagnostic ToolsCarolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).
Latest:
FISH in focus for fast eye infection diagnosisDespite cost, advantages include sensitivity, improved outcomes
Latest:
ST laser therapy may reduce DME intravitreal injectionsUsed as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.
